Michelle Lai

Appearances

LIVER DISEASE ACTIVITY IS A SIGNIFICANT RISK FACTOR FOR CARDIOVASCULAR OUTCOMES -A PROSPECTIVE ANALYSIS OF 33,616 INDIVIDUALS FROM THE UK BIOBANK
Date
May 7, 2023
It is controversial whether glucagon-like peptide 1 (GLP-1) receptor agonists (RA) are associated with adverse pancreatic, gallbladder or biliary outcomes…
Presenter
Adriana Roca-Fernandez
Speakers
Rajarshi Banerjee
Helena Thomaides-Brears
Alison Telford
Arun Sanyal
Stefan Neubauer
Thomas Nichols
Betty Raman
Celeste McCracken
Steffen Petersen
Ntobeko Ntusi
Daniel Cuthbertson
Michelle Lai
Andrea Dennis
Amitava Banerjee
VLDL LIPIDOMIC PROFILING REVEALS ALTERED GLUCOSYLCERAMIDE METABOLISM IN NONALCOHOLIC FATTY LIVER DISEASE RELATED LIVER FIBROSIS
Date
May 19, 2024
BACKGROUND: The secretion of very low-density lipoprotein (VLDL) is the primary mechanism by which hepatocytes remove lipids from its cellular organelles into the circulation. It is produced entirely by the liver and has a short-half life in the circulation…
Presenter
David Guardamino Ojeda
Speakers
Yusuf Yalcin
Michelle Lai
Zhenghui Jiang